Navigation Links
MIGENIX Second Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
Date:11/30/2007

Company to Report Interim Celgosivir 4-Week Viral Kinetics Study Data on

Monday December 3, 2007

VANCOUVER and SAN DIEGO, Nov. 30 /PRNewswire-FirstCall/ - MIGENIX Inc. (TSX: MGI; OTC: MGIFF), a clinical-stage developer of drugs for infectious diseases, will host a conference call and webcast on Thursday, December 13, 2007 at 11:00 a.m. ET (8:00 a.m. PT) to discuss financial results for the second fiscal quarter ended October 31, 2007 and provide an update on company activities. To participate in the conference call, please dial 416-644-3418 or 1-800-732-1073. The call will be available for replay until December 27, 2007 by calling 416-640-1917 or 1-877-289-8525 and entering the pass code 21255722 (followed by the number sign). The live and archived webcast can be accessed through the company's website at http://www.migenix.com for the next 90 days.

Additionally, the Company will report interim 4-week data from a Phase II viral kinetics combination study of celgosivir in patients with chronic HCV (genotype 1) infection on Monday December 3, 2007.

About MIGENIX

MIGENIX is committed to advancing therapy, improving health, and enriching life by developing and commercializing drugs primarily in the area of infectious diseases. The Company's clinical programs include drug candidates for the treatment of chronic hepatitis C infections (Phase II and preclinical), the prevention of catheter-related infections (Phase III) and the treatment of dermatological diseases (Phase II). MIGENIX is headquartered in Vancouver, British Columbia, Canada with US operations in San Diego, California. Additional information can be found at http://www.migenix.com.

"Jim DeMesa"

James M. DeMesa, M.D.

President & CEO

CONTACT: Art Ayres, MIGENIX Inc., Tel: (604) 221-9666 Ext. 233, aayres@migenix.com; Dian
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MIGENIX First Fiscal Quarter 2008 Financial Results Conference Call & Webcast Notification
2. MIGENIX to Present Positive Celgosivir Viral Resistance Data at International HCV Meeting
3. MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
4. MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
5. Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists
6. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
7. Skystar Bio-Pharmaceutical Announces Second Quarter 2007 Results
8. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
9. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
10. Carrington Reports Second Quarter 2007 Results
11. Response Genetics Reports Second Quarter 2007 Financial Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).... 25 Reportlinker.com announces th...s catalogue: ,, Brazil Bioethanol Market Analy...tlinker.com/p0165503/Brazil-Bioethanol-Market-Anal...thanol Market Analysis and Forecasts to 2013 ,,...ysis and forecasts of the global bioethanol market...
(Date:11/24/2009)...4 IES (Nasdaq: IESC ), ...unications systems and services for the commercial...day that its commercial business group has been aw...ll the electrical systems for the Level 4 bio-safe...my Medical Research Institute of Infectious Diseas...
(Date:11/24/2009)...if., Nov. 24 Two more prestigious ...tion,s leading online job board and careers site f...and Columbia University are now members of the job...ng Institutions. ,, The job board, www.biocare...ife sciences. While there are hundreds of life sci...
(Date:11/24/2009)...24 Sigma-Aldrich Corpora...SDAQ OMX conference on Tuesday, December 1st at 1:...rties may listen via live audio broadcast over the...m a a ldrich.com/ . Users can click the "Webc...ma-Aldrich: Sigma-Aldrich is a leading Life Scie...
Breaking Biology Technology:Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2
...beron FMR, Inc. was selected as the most promising...08 Venture Showcase Competition. Oberon, which us...m food and beverage companies into a protein-rich ...ut of 22 total entries by a panel consisting of fi...lorado law firm of Dorsey & Whitney, one local...
... Align Technology,Inc. (Nasdaq: ALGN ) today ann...om the Japanese Ministry of Health, Labour and Wel... marketing and promotion of Invisalign in Japan, w...rthodontists since launching the,product there in ...n Japan is an important milestone and will,enable ...
...Pharmacopeia (USP) Convention,an official public s...d,over-the-counter medicines sold in the United St...ownership and management of the overall MEDMARX,re...mes one year after Quantros,and USP formalized a s...operations, support, marketing and sales for the M...
Other Biology Technology:Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 2Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 3Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 4Oberon FMR Wins Top Prize at BioWest 2008 Venture Showcase Competition 5Align Technology Receives Expanded Regulatory Approval in Japan 2Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 2Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 3Quantros Acquires MEDMARX(R) from United States Pharmacopeia (USP) 4
(Date:11/24/2009)...et science is opening new doors to understanding h...the hearing of a marine mammal or if they hear it...ed X-ray scanners that NASA uses to detect flaws i...is now allowing scientists to peek inside the gian...d three-dimensional replicas of a whale,s hearing ...
(Date:11/24/2009)...atomic-level action of a remarkable class of ring-...chers with the Lawrence Berkeley National Laborato... crystallography beamline at the Advanced Light So...s in gene expression and replication, and are vita... as infectious agents, such as the human papilloma...
(Date:11/24/2009)...TON ROUGE Antarctica has long held secrets of the...il recently, there has been very little informatio...h miles of ice for millions of years. Now, a team ...SU have been funded to the tune of $10 million do...to get to the bottom of things literally. These s...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4LSU gets to the bottom of things -- in Antarctica 2Recession Takes Toll on Childrens Health 52051 1Recession Takes Toll on Childrens Health 52051 2Small Molecule Might Play Big Part in Lung Cancer 52049 1Small Molecule Might Play Big Part in Lung Cancer 52049 2Small Molecule Might Play Big Part in Lung Cancer 52049 3iCRco Conducts 2009 Asia Pacific Distributor Training Program 52047 1iCRco Conducts 2009 Asia Pacific Distributor Training Program 52047 2iCRco Conducts 2009 Asia Pacific Distributor Training Program 52047 3
...tists who set out to study sex pheromones in a tin...so controls a stage in the worms, life cycle, the ...ed in Nature online on July 23, represent the fi...linked through so-called small molecules. , Whe...the major players in an organism,s biology, they a...
... the heart grow fonder, but endurance exercise see...ted at Washington University School of Medicine in...e training for about a year ended up with metaboli...owed that by one metabolic measure, women benefite...t the heart deteriorates as people get older, and ...
...oday announced the online publication of the first... interdisciplinary journal for the scientific comm...ral issue contains articles on solar cells, hybrid...uel production, sustainable energy, and much more.... of the highest quality, knowing that they can rel...
Other Biology News:Sex and lifespan linked in worms 2Exercise could be the heart's fountain of youth 2Exercise could be the heart's fountain of youth 3
... highly integrated comprehensive environment for D...logy data management available on Mac OS X. With V...transform share and publicize diverse types of mol...ysis environment. State-of-the-Art Sequence Anal...
...eight determinations for petroleum-based applicati..., benzene, formamide, nitrobenzene, cyclohexane, 1...2, cyclohexanol, sulfolane. ... ...
Rat Leptin from BioVision
Sheep Anti-ESCHERICHIA COLI (STABLE TOXIN (ST)) Polyclonal Antibody, Unconjugated from AbD Serotec
Biology Products: